1007455-32-4 Usage
Fluorinated derivative
A derivative of isoindolone with a fluorine atom The compound is a modified version of the isoindolone structure, with a fluorine atom attached to the 7-carbon atom.
Heterocyclic organic compound
Contains a hydroxyl group and a fluorine atom The compound has a ring structure containing both carbon and hetero atoms (such as nitrogen and oxygen), with a hydroxyl group attached to the 6-carbon atom and a fluorine atom on the 7-carbon atom.
Pharmaceutical research and development
Used in the synthesis of potential drug candidates The compound is utilized in creating new drugs and studying their biological activities, making it a valuable resource in the pharmaceutical industry.
Biological activity
Potential pharmacological properties Due to its unique structural features, 1H-Isoindol-1-one, 7-fluoro-2,3-dihydro-6-hydroxy may exhibit pharmacological properties that could be beneficial in medicinal chemistry and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 1007455-32-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,7,4,5 and 5 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1007455-32:
(9*1)+(8*0)+(7*0)+(6*7)+(5*4)+(4*5)+(3*5)+(2*3)+(1*2)=114
114 % 10 = 4
So 1007455-32-4 is a valid CAS Registry Number.
1007455-32-4Relevant academic research and scientific papers
Synthesis of methyl-, fluoro-, and chloro-substituted 6-hydroxyisoindolin-1-ones
Powers, James J.,Favor, David A.,Rankin, Trent,Sharma, Rashmi,Pandit, Chetan,Jeganathan, Azhwarsamy,Maiti, Samarendra N.
supporting information; experimental part, p. 1267 - 1269 (2009/09/05)
The synthesis of a series of methyl-, fluoro-, and chloro-substituted 6-hydroxyisoindolin-1-ones is described.
ISOINDOLE DERIVATIVES
-
Page/Page column 31; 33, (2010/11/30)
This invention relates to compounds of formula (I) or pharmaceutically acceptable salts thereof, a process of making these compounds, pharmaceutical compositions containing one or more of these compounds or their salts, and their use for the treatment of schizophrenia, bipolar disorder, or other central nervous system disorders.
